People with the kind of health anxiety formerly referred to as hypochondriasis used to have to go to the doctor’s office to quell their concerns. Thanks to a new crop of apps, they can now just take out a smartphone and reach a health professional anytime, from anywhere.
Studies suggest that health anxiety—more recently termed somatic symptom disorder and illness anxiety disorder—affects anywhere from less than 1 percent to as much as nearly 12 percent of the population. For some of these people, a new array of telemedicine apps like MDLive and Doctor on Demand are appealing because they take insurance and also let you pay up front at cost of about $40 to $50 for a short video or phone consult.
Because they are so easy to use, some medical experts wonder whether, over time, telemedicine apps will encounter a disproportionate number of users with health anxiety disorders. Already, app makers are encountering the ethical question of whether they should encourage such users to seek mental help.
MDLive’s chief medical affairs officer, Deborah Mulligan, says that the company’s app has 28 million registered users, and it’s likely that about 6 percent have this condition, which mirrors the proportion found in the general population. What makes matters more complex is that with any other type of mobile technology, these people would be considered “super users” who drive revenue—the kinds of folks you want to stick around and keep using the app all the time.
Mulligan spent much of her career working in emergency rooms and was trained to recognize the symptoms of health-related anxiety disorders, which include worrying about a disease when there are no symptoms, experiencing high anxiety about minor aches and pains, and not feeling reassured by negative test results. She recalls one MDLive patient who exhibited all of these symptoms, and who suggested setting up regular consults to discuss a specific health condition that the patient didn’t have. After several sessions to build up trust, Mulligan recommended that the patient try MDLive’s cognitive behavioral therapy service.
“They contacted me to thank me,” she says. “It was like a weight off their shoulders.”
Doctor on Demand board member Bob Kocher says that the majority of people who use the app are calling up about routine symptoms, like colds and the flu. He isn’t aware of patients with health-related anxiety regularly using the app to discuss their symptoms. However, he thinks it’s possible that more such patients will discover the app as it gains mainstream recognition.
“Frankly, I think there are some of these patients in the health system who haven’t found us yet,” he says. “I’m sure we’ll have board meetings someday about a patient who used us 20 times that week.”
Kocher says that app makers might make a “lot of money” through these interactions but will have a responsibility to investigate whether the cases were handled well.
One of the challenges of finding these kinds of users, experts say, is the lack of information transparency, particularly as the apps don’t share data with each other. “We don’t really know who the frequent users are,” says John Torous, co-director of the digital psychiatry program at Beth Israel Deaconess Medical Center. “It’s a population that is not well characterized.”
And Doctor on Demand’s chief medical officer, Ian Tong, points out that excessive health anxiety might be challenging to monitor if patients use an array of different apps.
“You might not be able to tell unless the person was being prescribed a lot of medications,” he admits.
This startup wants to copy you into an embryo for organ harvesting
With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.
VR is as good as psychedelics at helping people reach transcendence
On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.
This nanoparticle could be the key to a universal covid vaccine
Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.
This artist is dominating AI-generated art. And he’s not happy about it.
Greg Rutkowski is a more popular prompt than Picasso.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.